A Comparison of Dabigatran With Warfarin for Stroke Prevention in Atrial Fibrillation in an Asian Population

Conclusion:
There were similar rates of efficacy for outcomes of ischemic CVA, hemorrhagic CVA, and bleeding when comparing dabigatran with warfarin. Our study shows that despite similar efficacy, suboptimal TTR rates and inconveniences with warfarin demonstrate that NOACs are preferred for stroke prevention in AF.

Source: Clinical and Applied Thrombosis/Hemostasis - October 6, 2016 Category: Hematology Authors: Yap, L. B., Eng, D. T. S., Sivalingam, L., Rusani, B. I., Umadevan, D., Muhammad, Z., Koh, K. W., Aisha, B., Hashim, M. I., Rebo, R., Hussin, A., Kaur, S., Shanmugam, R., Omar, R. Tags: Original Articles Source Type: research